Edition:
United Kingdom

Geron Corp (GERN.OQ)

GERN.OQ on NASDAQ Stock Exchange Global Select Market

1.38USD
7:29pm BST
Change (% chg)

$-0.06 (-4.51%)
Prev Close
$1.44
Open
$1.42
Day's High
$1.45
Day's Low
$1.37
Volume
140,464
Avg. Vol
376,826
52-wk High
$6.99
52-wk Low
$0.95

About

Geron Corporation (Geron) is a biopharmaceutical company, which supports the clinical stage development of a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies by Janssen Biotech, Inc. (Janssen). The Company is engaged in the development of therapeutic products for oncology. Using its nucleic acid chemistry,... (more)

Overall

Beta: 2.64
Market Cap(Mil.): $366.19
Shares Outstanding(Mil.): 159.21
Dividend: --
Yield (%): --

Financials

  GERN.OQ Industry Sector
P/E (TTM): -- 69.38 32.67
EPS (TTM): -0.16 -- --
ROI: -21.08 8.95 14.48
ROE: -21.08 10.09 15.78
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates